Latest News about MRK
Recent news which mentions MRK
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
3 No-Brainer Warren Buffett Stocks to Buy Right Now
September 14, 2021
From Motley Fool
Why Are Silverback Therapeutics Shares Falling On Monday?
September 13, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
3 Dow Jones Stocks to Buy Hand Over Fist Right Now
September 12, 2021
From Motley Fool
How Keytruda's Latest Approval in China Boosts Merck
September 11, 2021
From Motley Fool
3 Smartest Big Pharma Stocks to Buy in September
September 11, 2021
From Motley Fool
8 Health Care Stocks With Unusual Options Alerts In Today's Session
September 10, 2021
From Benzinga
Codexis, Merck Extend Supply Pact For Enzyme Used To Manufacture Sitagliptin
September 10, 2021
From Benzinga
Is Moderna's Stock Still Cheap?
September 09, 2021
From Benzinga
Coca-Cola And Merck Lead The Dow Jones Lower
September 09, 2021
From Benzinga
3 Red-Hot Healthcare Stocks to Buy in September
September 09, 2021
From Motley Fool
Moderna Shares Gain Amid R&D Day Presentations: What You Need To Know
September 09, 2021
From Benzinga
3 Effective Strategies for Finding Value in Any Market
September 09, 2021
From Motley Fool
Merck Investors Have Reason to Cheer This Label Expansion
September 09, 2021
From Motley Fool
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?
September 09, 2021
From Motley Fool
Downgrades On Economy And Pandemic Pharmaceuticals
September 08, 2021
From Benzinga
3 Warren Buffett Stocks to Buy in September
September 08, 2021
From Motley Fool
Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley
September 07, 2021
From MarketWatch
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
September 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
September 07, 2021
From Benzinga
3 Value Stocks That'll Make You Richer in September (and Beyond)
September 07, 2021
From Motley Fool
14 dividend stocks from a winning value manager as the broader market hits record highs
September 03, 2021
From MarketWatch
Pfizer Commences Dosing In Pivotal Oral COVID-19 Drug Trial
September 01, 2021
From Benzinga
Merck To Test Oral Antiviral Candidate For Post-Exposure Prophylaxis Of COVID-19 Infection
September 01, 2021
Tickers
MRK
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
FDA Extends Full Approval For Merck's Keytruda In 1st-Line Bladder Cancer
September 01, 2021
Tickers
MRK
From Benzinga
Pete Najarian Sees Unusual Options Activity In Merck And FXI
August 31, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.